Aegerion Pharmaceuticals, Inc. (AEGR) Announces Presentation At The Cowen And Company Healthcare Conference
2/28/2014 9:37:42 AM
CAMBRIDGE, Mass., Feb. 27, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, announced today that the company will participate in the Cowen and Company 34th Annual Healthcare Conference in Boston. Marc Beer, Chief Executive Officer of Aegerion, is scheduled to present on Tuesday, March 4, 2014 at 8:00 a.m. ET.
Help employers find you! Check out all the jobs and post your resume.
comments powered by